Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
FOXO TECHNOLOGIES INC.
foxotechnologies.comAI Executive Summary
AI-powered analysis of 8-K filing content
FOXO Technologies entered into a Strategic Technology License Agreement with Jon R. Sabes and LongevityFP Technologies, LLC on May 27, 2026, granting an exclusive worldwide license to commercialize FOXO's epigenetics intellectual property portfolio including two U.S. patents and a dataset of over 13,000 epigenetic data points. This represents a significant commercialization expansion for FOXO's biotech intellectual property.
Key Takeaways
FOXO granted LongevityFP an exclusive, worldwide license to commercialize its epigenetics IP portfolio, including U.S. Patent Nos. 11,795,495 and 11,817,214
The agreement includes access to a proprietary dataset containing over 13,000 epigenetic data points and proprietary machine learning technologies
2 more takeaways